Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05365425
PHASE4

Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

Sponsor: Seoul National University Bundang Hospital

View on ClinicalTrials.gov

Summary

This is a randomized controlled study to assess the effect of choline fenofibrate compared with policosanol in Korean T2DM patients with asymptomatic atherosclerosis.

Official title: Effect of Choline Fenofibrate on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes and Combined Dyslipidemia

Key Details

Gender

All

Age Range

20 Years - Any

Study Type

INTERVENTIONAL

Enrollment

56

Start Date

2023-06-01

Completion Date

2026-12-31

Last Updated

2024-05-01

Healthy Volunteers

No

Interventions

DRUG

Choline fenofibrate

choline fenofibrate 178.8mg (135mg as fenofibric acid)

DRUG

Policosanol

policosanol 10mg

Locations (1)

SNUBH

Seongnam-si, Gyeonggi-do, South Korea